Diffuse noxious inhibitory controls and nerve injury: Restoring an imbalance between descending monoamine inhibitions and facilitations

Pain

Volumn 156, Issue 9, 2015, Pages 1803-1811

  Bannister, Kirsty ^a   Patel, Ryan ^a   Goncalves, Leonor ^a   Townson, Louisa ^a   Dickenson, Anthony H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Adrenoceptors; Conditioned pain modulation; Descending facilitations; Descending inhibitions; Diffuse noxious inhibitory controls; Dorsal horn; In vivo electrophysiology; Monoamines; Neuropathic pain

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ATIPAMEZOLE; MONOAMINE; ONDANSETRON; REBOXETINE; SEROTONIN 3 RECEPTOR; TAPENTADOL; YOHIMBINE; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BIOGENIC AMINE; DULOXETINE; PHENOL DERIVATIVE; SEROTONIN ANTAGONIST; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ELECTROPHYSIOLOGY; COMPARATIVE STUDY; CONDITIONED REFLEX; CONTROLLED STUDY; DIFFUSE NOXIOUS INHIBITORY CONTROL; EVOKED RESPONSE; FACILITATION; HIND PAW; IN VIVO STUDY; LOW DRUG DOSE; MALE; MECHANICAL STIMULATION; MONOAMINERGIC SYSTEM; NERVE LIGATION; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; RECEPTIVE FIELD; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SPINAL CORD DORSAL HORN; SPINAL NERVE LIGATION INJURY; VON FREY TEST; ACTION POTENTIAL; ANALYSIS OF VARIANCE; ANIMAL; ANTAGONISTS AND INHIBITORS; CONVALESCENCE; DISEASE MODEL; DRUG EFFECTS; METABOLISM; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL NERVE INJURIES; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TIME FACTOR;

ACTION POTENTIALS; ADRENERGIC ALPHA-2 RECEPTOR ANTAGONISTS; ANALYSIS OF VARIANCE; ANIMALS; BIOGENIC MONOAMINES; DIFFUSE NOXIOUS INHIBITORY CONTROL; DISEASE MODELS, ANIMAL; DULOXETINE HYDROCHLORIDE; EVOKED POTENTIALS; MALE; NEURONS; ONDANSETRON; PERIPHERAL NERVE INJURIES; PHENOLS; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SEROTONIN AND NORADRENALINE REUPTAKE INHIBITORS; SEROTONIN ANTAGONISTS; TIME FACTORS; YOHIMBINE;

EID: 84964627179     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1097/j.pain.0000000000000240     Document Type: Article

References (37)

1. Arendt-Nielsen L, Nie H, Laursen MB, Laursen BS, Madeleine P, Simonsen OH, Graven-Nielsen T. Sensitization in patients with painful knee osteoarthritis. PAIN 2010;149:573-81.
2. Bannister K, Bee LA, Dickenson AH. Preclinical and early clinical investigations related to monoaminergic pain modulation. Neurotherapeutics 2009;6: 703-12.
3. Baron R, Tolle TR, Gockel U, Brosz M, Freynhagen R. A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: differences in demographic data and sensory symptoms. PAIN 2009;146:34-40.
4. Bauer CS, Nieto-Rostro M, Rahman W, Tran-Van-Minh A, Ferron L, Douglas L, Kadurin I, Sri Ranjan Y, Fernandez-Alacid L, Millar NS, Dickenson AH, Lujan R, Dolphin AC. The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin. J Neurosci 2009;29:4076-88.
5. Bee LA, Bannister K, Rahman W, Dickenson AH. Mu-opioid and noradrenergic alpha(2)-adrenoceptor contributions to the effects of tapentadol on spinal electrophysiological measures of nociception in nerve-injured rats. PAIN 2011;152:131-9.
6. Bouhassira D, Bing Z, Le Bars D. Studies of the brain structures involved in diffuse noxious inhibitory controls: The mesencephalon. J Neurophysiol 1990;64:1712-23.
7. Bouhassira D, Bing Z, Le Bars D. Effects of lesions of locus coeruleus/subcoeruleus on diffuse noxious inhibitory controls in the rat. Brain Res 1992;571:140-4.
8. Bouhassira D, Chitour D, Villanueva L, Le Bars D. Morphine and diffuse noxious inhibitory controls in the rat: effects of lesions of the rostral ventromedial medulla. Eur J Pharmacol 1993;232:207-15.
9. Bouhassira D, Villanueva L, Bing Z, le Bars D. Involvement of the subnucleus reticularis dorsalis in diffuse noxious inhibitory controls in the rat. Brain Res 1992;595:353-7.
10. Danziger N, Gautron M, Le Bars D, Bouhassira D. Activation of diffuse noxious inhibitory controls (DNIC) in rats with an experimental peripheral mononeuropathy. PAIN 2001;91:287-96.
11. De Felice M, Sanoja R, Wang R, Vera-Portocarrero L, Oyarzo J, King T, Ossipov MH, Vanderah TW, Lai J, Dussor GO, Fields HL, Price TJ, Porreca F. Engagement of descending inhibition from the rostral ventromedial medulla protects against chronic neuropathic pain. PAIN 2011;152:2701-9.
12. Dickenson AH, Rivot JP, Chaouch A, Besson JM, Le Bars D. Diffuse noxious inhibitory controls (DNIC) in the rat with or without pCPA pretreatment. Brain Res 1981;216:313-21.
13. Dogrul A, Ossipov MH, Porreca F. Differential mediation of descending pain facilitation and inhibition by spinal 5HT-3 and 5HT-7 receptors. Brain Res 2009;1280:52-9.
14. Hay JL, White JM, Bochner F, Somogyi AA, Semple TJ, Rounsefell B. Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients. J Pain 2009;10:316-22.
15. Hodge CJ Jr, Apkarian AV, Stevens RT, Vogelsang GD, Brown O, Franck JI. Dorsolateral pontine inhibition of dorsal horn cell responses to cutaneous stimulation: lack of dependence on catecholaminergic systems in cat. J Neurophysiol 1983;50:1220-35.
16. Hughes SW, Hickey L, Hulse RP, Lumb BM, Pickering AE. Endogenous analgesic action of the pontospinal noradrenergic system spatially restricts and temporally delays the progression of neuropathic pain following tibial nerve injury. PAIN 2013;154:1680-90.
17. Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. PAIN 1992;50: 355-63.
18. Kraus E, Le Bars D, Besson JM. Behavioral confirmation of "diffuse noxious inhibitory controls" (DNIC) and evidence for a role of endogenous opiates. Brain Res 1981;206:495-9.
19. Lautenbacher S, Prager M, Rollman GB. Pain additivity, diffuse noxious inhibitory controls, and attention: A functional measurement analysis. Somatosens Mot Res 2007;24:189-201.
20. Le Bars D, Dickenson AH, Besson JM. Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn convergent neurones in the rat. PAIN 1979;6:283-304.
21. Le Bars D, Dickenson AH, Besson JM. Diffuse noxious inhibitory controls (DNIC). II. Lack of effect on non-convergent neurones, supraspinal involvement and theoretical implications. PAIN 1979;6:305-27.
22. Locke D, Gibson W, Moss P, Munyard K, Mamotte C, Wright A. Analysis of meaningful conditioned pain modulation effect in a pain-free adult population. J Pain 2014;15:1190-8.
23. Mendell LM, Wall PD. Responses of single dorsal cord cells to peripheral cutaneous unmyelinated fibres. Nature 1965;206:97-9.
24. Niesters M, Proto PL, Aarts L, Sarton EY, Drewes AM, Dahan A. Tapentadol potentiates descending pain inhibition in chronic pain patients with diabetic polyneuropathy. Br J Anaesth 2014;113:148-56.
25. Okada-Ogawa A, Porreca F, Meng ID. Sustained morphine-induced sensitization and loss of diffuse noxious inhibitory controls in durasensitive medullary dorsal horn neurons. J Neurosci 2009;29:15828-35.
26. Rahman W, D'Mello R, Dickenson AH. Peripheral nerve injury-induced changes in spinal alpha(2)-adrenoceptor-mediated modulation of mechanically evoked dorsal horn neuronal responses. J Pain 2008;9: 350-9.
27. Rempe T, Wolff S, Riedel C, Baron R, Stroman PW, Jansen O, Gierthmühlen J. Spinal fMRI reveals decreased descending inhibition during secondary mechanical hyperalgesia. PLoS One 2014;9:e112325.
28. Sikandar S, Ronga I, Iannetti GD, Dickenson AH. Neural coding of nociceptive stimuli-from rat spinal neurones to human perception. PAIN 2013;154:1263-73.
29. Suzuki R, Morcuende S, Webber M, Hunt SP, Dickenson AH. Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways. Nat Neurosci 2002;5:1319-26.
30. Suzuki R, Rahman W, Hunt SP, Dickenson AH. Descending facilitatory control of mechanically evoked responses is enhanced in deep dorsal horn neurones following peripheral nerve injury. Brain Res 2004;1019:68-76.
31. Urch CE, Dickenson AH. In vivo single unit extracellular recordings from spinal cord neurones of rats. Brain Res Brain Res Protoc 2003;12: 26-34.
32. Vanderah TW, Laughlin T, Lashbrook JM, Nichols ML, Wilcox GL, Ossipov MH, Malan TP Jr, Porreca F. Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone. PAIN 1996;68:275-81.
33. Villanueva L, Bing Z, Bouhassira D, Le Bars D. Encoding of electrical, thermal, and mechanical noxious stimuli by subnucleus reticularis dorsalis neurons in the rat medulla. J Neurophysiol 1989;61:391-402.
34. Yarnitsky D. Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states. Curr Opin Anaesthesiol 2010;23:611-5.
35. Yarnitsky D, Crispel Y, Eisenberg E, Granovsky Y, Ben-Nun A, Sprecher E, Best LA, Granot. Prediction of chronic post-operative pain: preoperative DNIC testing identifies patients at risk. PAIN 2008;138:22-8.
36. Yarnitsky D, Granot M, Nahman-Averbuch H, Khamaisi M, Granovsky Y. Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy. PAIN 2012;153:1193-8.
37. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. PAIN 1983;16:109-10.